Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors Running head: Neuropsychiatric outcomes in COVID-19 Raúl Méndez, MD 1,2,3, *; Vicent Balanzá-Martínez, MD PhD 4, *; Sussy C. Luperdi, MD 5,6, *, Itziar Estrada 6 , Ana Latorre, PhD 2 ; Paula González-Jiménez, MD 1,2 ; Laura Feced, MD 1,2 ; Leyre Bouzas, MD 1,2 ; Katheryn Yépez, MD 1,2 ; Ana Ferrando, MD 1,2 ; David Hervás, PhD 7 ; Enrique Zaldívar, MD 1,2 ; Soledad Reyes, MD PhD 1,2 ; Michael Berk, MD PhD 8,9 ; Rosario Menéndez, MD PhD 1,2,6,10 . 1 Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain. 2 Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain. 3 University of Barcelona. Barcelona, Spain. 4 Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Valencia, Spain. 5 Psychiatry Department. La Fe University and Polytechnic Hospital. Valencia, Spain. 6 University of Valencia. Valencia, Spain. 7 Data Science, Biostatistics & Bioinformatics. Health Research Institute La Fe. Valencia, Spain. 8 Deakin University, IMPACT – the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia. 9 Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. ; https://doi.org/10.1101/2020.09.23.20190090 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.